Page results
-
Our Getting Ready for Transition (GReaT) to secondary school parent information session will run on Wednesday 28 January 2026.
-
UCLH is to trial a COVID-19 vaccine developed by Imperial College London.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Dr Junaid Bajwa became a non-executive director at UCLH in September 2018. He was born at UCLH and is a practising GP with experience of serving a deprived London community.
-
The huge impact the COVID-19 crisis is having on our patients and staff was the focus of a BBC News report broadcast tonight (Sunday).
-
UCLH has retendered and awarded five-year contracts to two companies to provide estates and facilities services across UCLH.
-
Breathing aids developed by engineers at UCL, UCLH and Mercedes-AMG High Performance Powertrains have been delivered to 40 NHS hospitals across the country.
-
A critical care nurse at The National Hospital for Neurology and Neurosurgery, Helen Burgess, has produced a short film to provide reassurance to relatives unable to visit their loved ones because of visitor restrictions during the Covid-19 pandemic.
-
In his darkest moments, coronavirus patient Ertan Nazim feared he wouldn’t live to celebrate his 44th wedding anniversary.
-
Simon Porter joined UCLH as a non-executive director on 1 April 2020. He is a chartered accountant whose executive career at the London office of Ernst & Young ranged across audit, corporate finance and risk management.
File results
-
Council of Governors meeting papers - 31 October
-
Consultant - to -consultant referral form
-
UCLH Provider to Provider Tariff 2019-20
-
What young people would like everyone to know about Type 1 Diabetes
-
Reverse mentoring
-
FOI/2020/0572 - Inflamatory bowel disease staff contact details
-
FOI2017294 Contactors and subcontractors working on the Phase 4 and proton therapy beam
-
FOI/2020/0589 - Senior staff contacts for CEO, Director of Innovation and Chief Pharmacist
-
FOI/2020/0630 - CEO, Operations Director and Health and Safety Director contact details
-
FOI2017333 Midwifery contacts for accessing return to practice placements